PMV Pharmaceuticals, Inc. Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
PMV Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • PMV Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -24.2 %, a 22.3% increase year-over-year.
  • PMV Pharmaceuticals, Inc. annual Return On Equity for 2023 was -30.3 %, a 11% decline from 2022.
  • PMV Pharmaceuticals, Inc. annual Return On Equity for 2022 was -27.3 %, a 55.4% decline from 2021.
  • PMV Pharmaceuticals, Inc. annual Return On Equity for 2021 was -17.5 %, a 28% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -30.3 -3.01 -11% Jan 1, 2023 Dec 31, 2023
2022 -27.3 -9.72 -55.4% Jan 1, 2022 Dec 31, 2022
2021 -17.5 +6.82 +28% Jan 1, 2021 Dec 31, 2021
2020 -24.4 -66 -159% Jan 1, 2020 Dec 31, 2020
2019 41.6 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.